BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8629811)

  • 1. Terminal deletion in chromosome region 8p23.1-8pter in a child with features of velo-cardio-facial syndrome.
    Devriendt K; De Mars K; De Cock P; Gewillig M; Fryns JP
    Ann Genet; 1995; 38(4):228-30. PubMed ID: 8629811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal phenotype and slight mental retardation in de novo distal 8p deletion (8pter----8p23.1:).
    Fryns JP; Kleczkowska A; Vogels A; Van den Berghe H
    Ann Genet; 1989; 32(3):171-3. PubMed ID: 2573313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype.
    Tsai CH; Van Dyke DL; Feldman GL
    Am J Med Genet; 1999 Feb; 82(4):336-9. PubMed ID: 10051168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distal 8p deletion (8)(p23.1): an easily missed chromosomal abnormality that may be associated with congenital heart defect and mental retardation.
    Wu BL; Schneider GH; Sabatino DE; Bozovic LZ; Cao B; Korf BR
    Am J Med Genet; 1996 Mar; 62(1):77-83. PubMed ID: 8779331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [22q11.2 chromosome deletion and velo-cardio-facial syndrome in a patient with tetralogy of Fallot].
    Morava E; Masszi G; Czakó M; Tóth G; Melegh B; Kosztolányi G
    Orv Hetil; 2000 Aug; 141(34):1873-5. PubMed ID: 11006712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience.
    Vantrappen G; Rommel N; Devriendt K; Cremers CW; Feenstra L; Fryns JP
    Acta Otorhinolaryngol Belg; 2001; 55(1):43-8. PubMed ID: 11256191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual abilities in a large sample of children with Velo-Cardio-Facial Syndrome: an update.
    De Smedt B; Devriendt K; Fryns JP; Vogels A; Gewillig M; Swillen A
    J Intellect Disabil Res; 2007 Sep; 51(Pt 9):666-70. PubMed ID: 17845235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shprintzen (velo-cardio-facial) syndrome: a rare case.
    Alkan T; Akçevin A; Türkoglu H; Paker T; Aytaç A
    ASAIO J; 2006; 52(6):e33-4. PubMed ID: 17117043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural tube defects and deletions of 22q11.
    Nickel RE; Magenis RE
    Am J Med Genet; 1996 Dec; 66(1):25-7. PubMed ID: 8957506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Velo-cardio-facial syndrome: guidelines for diagnosis, treatment and follow-up of ent manifestations.
    Vantrappen G; Rommel N; Swillen A; Cremers CW; Fryns JP; Devriendt K
    Acta Otorhinolaryngol Belg; 2003; 57(2):101-6. PubMed ID: 12836465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with a 22q11 deletion versus children with a speech-language impairment and learning disability: behavior during primary school age.
    Swillen A; Devriendt K; Ghesquière P; Fryns JP
    Genet Couns; 2001; 12(4):309-17. PubMed ID: 11837599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-gated calcium channel gamma 2 subunit gene is not deleted in velo-cardio-facial syndrome.
    Black JL; Krahn LE; Jalal SM
    Mol Psychiatry; 2001 Jul; 6(4):461-4. PubMed ID: 11443534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
    Swillen A; Devriendt K; Legius E; Prinzie P; Vogels A; Ghesquière P; Fryns JP
    Genet Couns; 1999; 10(1):79-88. PubMed ID: 10191433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience.
    Vantrappen G; Devriendt K; Swillen A; Rommel N; Vogels A; Eyskens B; Gewillig M; Feenstra L; Fryns JP
    Genet Couns; 1999; 10(1):3-9. PubMed ID: 10191424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
    Lachman HM; Morrow B; Shprintzen R; Veit S; Parsia SS; Faedda G; Goldberg R; Kucherlapati R; Papolos DF
    Am J Med Genet; 1996 Sep; 67(5):468-72. PubMed ID: 8886163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
    Gothelf D; Schaer M; Eliez S
    Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proximal 4p syndrome in a 7-year-old moderately retarded girl].
    Volleth M; Erhardt J; Schmitzer E; Pfeiffer RA
    Monatsschr Kinderheilkd; 1993 Aug; 141(8):655-8. PubMed ID: 8377770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Velo-cardio-facial syndrome: a distinctive behavioral phenotype.
    Shprintzen RJ
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):142-7. PubMed ID: 10899808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.